Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year.

The order, signed in October 2023, required companies building powerful AI systems to share their safety test results with ...

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

AI creatives with access to Google’s Veo 2 text-to-video tool say it’s another “leap forward” for video generation Veo 2 ...

As it looks to accelerate the pace of its AI development, Google is streamlining the teams building its AI services, ...

Google DeepMind Chief Operations Officer Lila Ibrahim discussed the changes that the Trump administration may bring, ...

Demis Hassabis is the CEO of Google DeepMind. Demis thinks new agent type systems will be able to perform additional tree of knowledge search to achieve ...

Google DeepMind AI for Science Scholarships are now available, offering African students the opportunity to pursue ...

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...

Google challenges OpenAI with free Gemini 2.0 Flash Thinking model, offering million-token processing, native code execution, and breakthrough performance in math and science benchmarks.

Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its ...

Project Astra uses your phone camera or camera-equipped glasses to see the world around it and analyze what it sees.